Correlation Between Biotechnology Ultrasector and Alger Midcap

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Alger Midcap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Alger Midcap into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Alger Midcap Growth, you can compare the effects of market volatilities on Biotechnology Ultrasector and Alger Midcap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Alger Midcap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Alger Midcap.

Diversification Opportunities for Biotechnology Ultrasector and Alger Midcap

-0.18

Correlation Coefficient

Biotechnology Ultrasector  Alger Midcap

Good diversification

The 3 months correlation between Biotechnology and Alger is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Alger Midcap Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alger Midcap Growth and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Alger Midcap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alger Midcap Growth has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Alger Midcap go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Alger Midcap

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Alger Midcap. In addition to that, Biotechnology Ultrasector is 1.93 times more volatile than Alger Midcap Growth. It trades about -0.09 of its total potential returns per unit of risk. Alger Midcap Growth is currently generating about 0.11 per unit of volatility. If you would invest  1,492  in Alger Midcap Growth on September 27, 2024 and sell it today you would earn a total of  94.00  from holding Alger Midcap Growth or generate 6.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Alger Midcap Growth

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Alger Midcap Growth

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Alger Midcap Growth are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Alger Midcap may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Biotechnology Ultrasector and Alger Midcap

The main advantage of trading using opposite Biotechnology Ultrasector and Alger Midcap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Alger Midcap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alger Midcap will offset losses from the drop in Alger Midcap's long position.

The idea behind Biotechnology Ultrasector Profund and Alger Midcap Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.